In a filing, Regenxbio Inc revealed its Officer VITTAL VASISTA acquired Company’s shares for reported $0.15 million on Dec 30 ’24. In the deal valued at $7.41 per share,20,041 shares were bought.
Then, KARABELAS ARGERIS N sold 10,000 shares, generating $101,052 in total proceeds. Upon selling the shares at $10.11, the Director now owns 11,286 shares.
Before that, KARABELAS ARGERIS N sold 10,000 shares. Regenxbio Inc shares valued at $115,588 were divested by the Director at a price of $11.56 per share. As a result of the transaction, KARABELAS ARGERIS N now holds 11,286 shares, worth roughly $76293.36.
Goldman downgraded its Regenxbio Inc [RGNX] rating to a Neutral from a a Buy in a research note published on February 11, 2025; the price target was decreased to $14 from $38.
Price Performance Review of RGNX
On Tuesday, Regenxbio Inc [NASDAQ:RGNX] saw its stock fall -5.45% to $6.76. Over the last five days, the stock has lost -17.66%. Regenxbio Inc shares have fallen nearly -12.55% since the year began. Nevertheless, the stocks have fallen -67.92% over the past one year. While a 52-week high of $21.57 was reached on 03/19/25, a 52-week low of $5.62 was recorded on 03/04/25. SMA at 50 days reached $7.38, while 200 days put it at $9.84.
Levels Of Support And Resistance For RGNX Stock
The 24-hour chart illustrates a support level at 6.52, which if violated will result in even more drops to 6.28. On the upside, there is a resistance level at 7.09. A further resistance level may holdings at 7.42. The Relative Strength Index (RSI) on the 14-day chart is 41.59, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.79%. Stochastics %K at 38.34% indicates the stock is a holding.
How much short interest is there in Regenxbio Inc?
A steep rise in short interest was recorded in Regenxbio Inc stocks on 2025-03-14, dropping by -0.12 million shares to a total of 6.05 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 6.17 million shares. There was a decline of -1.99%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 07, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $38 price target.
